Investors Overview

About LB Pharmaceuticals

LB Pharmaceuticals is a neuromedicines company dedicated to developing and commercializing high-impact therapies that address the multiple dimensions of underserved brain disorders.

LB Pharmaceuticals Corporate Presentation

Press Releases

October 15, 2026

LB Pharmaceuticals to Participate in Upcoming Investor Events

October 10, 2026

LB Pharmaceuticals Presents New Preclinical Data Supporting LB-102’s Bimodal Mechanism of Action and Highlights Ongoing Late-Stage Clinical Development Programs at the 39th ECNP Congress

SEC Filings

Events

November 9, 2026

Guggenheim 3rd Annual Healthcare Innovation Conference

View Webcast

October 27, 2026

LB Pharma R&D Day: Advancing LB‑102 with a Focus on Schizophrenia Treatment